retatrutide weight loss clinical trial retatrutide Retatrutide: FDA approval time, results & ESC 2024: Retatrutide improves lipid

IV administration is used in some clinical settings to support liver function in patients with specific conditions - though this is not a reason to self-prescribe

Is GLP-1 microdosing safe for autoimmune conditions

Of the total cohort of participants, 47% of patients were women and the mean patient age was 66.2 years, the study results show

In one study, participants who followed an exercise programme maintained their weight even a year after the programme ended, while those who relied on medication alone were more likely to regain weight.[8] Current guidance from the World Health Organisation recommends aiming for at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week, plus two sessions of muscle-strengthening exercises.[9] Research shows that people who receive continued professional support after losing weight are more likely to maintain their results long-term.[10] When you come off GLP-1 medication, appetite, routine and motivation can all begin to shift, and working with a healthcare professional, dietitian or fitness specialist can help you navigate this transition